Trevi Therapeutics (TRVI) Tops Q4 EPS by 1c
Get Alerts TRVI Hot Sheet
Join SI Premium – FREE
Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: Walmart will be lowering prices
- LG Energy 2q Oper Profit 113.3b Won, Est. 210.66b Won - Bloomberg
- L3Harris wins $499.6M defense contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share